Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
310.20    -2.80 (-0.89%)
Bid:
311.20
Ask:
312.00
Spread: 0.80 (0.257%)
Market Cap: £1.08b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Interim Results

2 Sep 2009 15:14

RNS Number : 4174Y
Marwyn Materials Limited
02 September 2009
 



MARWYN MATERIALS LIMITED

UNAUDITED INTERIM RESULTS

FOR THE 6 MONTH PERIOD TO 30 JUNE 2009

Chairman's Statement

I am pleased to present the interim financial statements of Marwyn Materials Limited for the first six months of 2009.

Acquisition strategy

Marwyn Materials Limited was established to acquire controlling interests in building materials businesses, both listed and unquoted, in the UKEurope and US, with a view to creating shareholder value through market consolidation. This continued to be the group's strategy throughout the period under review.

Results

The group's loss after taxation for the period from incorporation to 30 June 2009 was £435,050 which was in line with the expected result for this period. 

Costs incurred to date include £75,000 in relation to due diligence carried out on acquisition targets by the group's professional advisers but with a large proportion of work carried out by the management.

As at 30 June 2009, the group had net cash balances totalling £12.5 million. 

Dividends

It is the board's policy that prior to making the first acquisition, no dividends will be paid. Following the first acquisition, subject to availability of distributable reserves, dividends will be paid to shareholders when the directors believe it is appropriate and prudent to do so. However, the main focus of the group will be on delivering capital growth for shareholders.

Outlook

The group continues to pursue its stated acquisition strategy. The short term trading performance for building materials businesses has remained difficult and we continue to review a number of opportunities to acquire attractive assets at a cyclical low point for the industry. 

We believe that Marwyn Materials, with its strong and experienced management team, is well placed to exploit the available opportunities as they arise. 

Peter Tom

Chairman

2nd September 2009

Enquiries: 

 

 

Marwyn Materials Limited 

Peter Tom 020 7389 6800 

Simon Vivian 020 7389 6800 

 

 

Cenkos Securities plc 

Nicholas Wells 020 7397 8920

 

 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 
 
30 June 2009 (unaudited)
 
31 December 2008 (audited)
 
 
£
 
£
 
Assets
 
 
 
 
 
 
 
 
 
 
 
Receivables
 
7,726
 
14,195
Cash and cash equivalents
 
12,450,273
 
12,806,100
Total current assets
 
12,457,999
 
12,820,295
Total assets
 
12,457,999
 
12,820,295
 
 
 
 
 
Equity
 
 
 
 
Share capital
 
13,262,480
 
13,262,480
Equity-settled employee benefits reserve
 
1,263
 
680
Accumulated losses
 
(1,177,545)
 
(742,495)
Total equity attributable to the shareholders of the Company
 
12,086,198
 
12,520,665
Total equity
 
12,086,198
 
12,520,665
 
 
 
 
 
Non-current liabilities
 
 
 
 
Taxation
 
5,048
 
1,913
Total non-current liabilities
 
5,048
 
1,913
 
 
 
 
 
Current liabilities
 
 
 
 
Trade and other payables
 
366,753
 
297,717
Total current liabilities
 
366,753
 
297,717
Total liabilities
 
371,801
 
299,630
Total equity and liabilities
 
12,457,999
 
12,820,295

These condensed interim financial statements were approved and authorised for issue by the Board of Directors on 2nd September 2009 and signed on its behalf by:

Peter Tom CBE Simon Vivian

Chairman Chief Executive

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the 6 months ended 30 June

 
 
2009 (unaudited) 
 
2008 (unaudited) 
 
 
£
 
£
 
 
 
 
 
Interest income
 
60,733
 
-
 
 
 
 
 
Employee expenses
 
(128,224)
 
-
Professional and consultancy expenses
 
(309,419)
 
(62,349)
Other expenses
 
(55,006)
 
(3,133)
 
 
(492,649)
 
(65,482)
 
 
 
 
 
Results from operating activities
 
(431,916)
 
(65,482)
 
 
 
 
 
Loss before income tax
 
(431,916)
 
(65,482)
 
 
 
 
 
Income tax expense
 
(3,134)
 
-
Loss for the period
 
(435,050)
 
(65,482)
Other comprehensive income
 
-
 
-
Total comprehensive income for the period
 
(435,050)
 
(65,482)
 
 
 
 
 
Attributable to:
 
 
 
 
Owners of the Company
 
(435,050)
 
(65,482)
Total comprehensive income for the period
 
(435,050)
 
(65,482)
 
 
 
 
 
Earnings per share
 
 
 
 
Basic and diluted loss per share
 
(0.32p)
 
(0.46p)

All the group's activities derive from continuing operations.

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the 6 months ended 30 June 2008 (unaudited)

 
 
 
 
 
 
 
Share capital
Equity-settled employee
 benefits
reserve
Accumulated losses
Total
 
 
£
£
£
£
 
Balance at 1 January 2008
2
 
-
(600)
(598)
 
Loss for the period
-
 
-
(65,482)
(65,482)
 
Other comprehensive income 
-
 
-
-
-
 
Total comprehensive income
-
 
-
(65,482)
(65,482)
 
Recognition of share-based payments 
-
 
93
-
93
 
Issue of ordinary shares during the period
13,599,998
-
-
13,599,998
 
Costs directly related to the issue of capital
(337,520)
-
-
(337,520)
 
 
Balance at 30 June 2008
13,262,480
 
93
(66,082)
13,196,491
 

For the 6 months ended 30 June 2009 (unaudited)

 
 
 
 
 
 
Share capital
Equity- settled employee
benefits
reserve
Accumulated losses
Total
 
 
£
£
£
£
 
Balance at 1 January 2009
13,262,480
 
680
(742,495)
12,520,665
 
Loss for the period
-
-
(435,050)
(435,050)
 
Other comprehensive income 
-
-
-
-
 
Total comprehensive income
-
-
(435,050)
(435,050)
 
Recognition of share-based payments 
-
583
-
583
 
Issue of ordinary shares during the period
 
 
 
 
 
Costs directly related to the issue of capital
 
 
 
 
 
Balance at 30 June 2009
13,262,480
1,263
(1,177,545)
12,086,198
 

All the group's activities derive from continuing operations.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

For the 6 months ended 30 June

 
 
 
2009
(unaudited) 
 
2008
(unaudited) 
 
 
 
£
 
£
 
 
 
 
 
 
Cash flows from operating activities:
 
 
 
 
 
Interest received
 
 
69,768
 
-
Payments to suppliers and employees
 
 
(425,595)
 
-
Net cash generated by operating activities
 
 
(355,827)
 
-
Cash flows from financing activities:
 
 
 
 
 
Proceeds from issue of share capital
 
 
-
 
13,600,000
Payment for share issue costs
 
 
-
 
(337,520)
Net cash from financing activities
 
 
-
 
13,262,480
 
 
 
 
 
 
Net decrease in cash and cash equivalents
 
 
(355,827)
 
13,262,480
Cash and cash equivalents at 1 January
 
 
12,806,100
 
-
Cash and cash equivalents at 30 June
 
 
12,450,273
 
13,262,480

1. Reporting entity

 

Marwyn Materials Limited (the "Company") is a company domiciled in Jersey. The address of the Company's registered office is Elizabeth House, 9 Castle Street, St Helier, JerseyJE2 3RT

The Company is listed on the Alternative Investment Market ("AIM").

This condensed consolidated interim financial information has not been audited and was approved for issue on 2nd September 2009.

 

 

2.Statement of compliance

 

These condensed consolidated interim financial statements for the six months ended 30 June 2009 have been prepared in accordance with International Accounting Standard (IAS) 34 'Interim Financial Reporting', as adopted by the European Union.  The condensed consolidated interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2008.

 

3. Accounting policies 

 

The accounting policies applied are consistent with those of the annual financial statements for the year ended 31 December 2008, as described in those annual financial statements, except for the adoption of new standards and interpretations as noted below:

− IAS 1 (revised), 'Presentation of financial statements'. The revised standard prohibits the presentation of items of income and expenses (that is 'non-owner change in equity') in the consolidated statement of changes in equity, requiring 'non-owner changes in equity' to be presented separately from owner changes in equity. All 'non-owner changes in equity' are required to be shown in a performance statement. Entities can choose whether to present one performance statement (the statement of comprehensive income) or two statements (the income statement and statement of comprehensive income). The group has elected to present one consolidated statement of comprehensive income. The interim financial statements have been prepared under the revised disclosure requirements which had no impact.

− IFRS 8, 'Operating segments'. IFRS 8 replaces IAS 14, 'Segment reporting'. It requires a 'management approach' under which segment information is presented on the same basis as that used for internal reporting purposes. This has not resulted in any change to the presentation. The Directors are of the opinion that the group is engaged in a single geographic and economic business segment. 

The International Accounting Standards Board's Annual Improvements Project was published in May 2008, with the majority of changes being applicable for the period commencing 1 January 2009. The project made minor amendments to a number of standards, primarily with a view to removing inconsistencies and clarifying wording. The amendments to these standards did not have any impact on the accounting policies, financial position or performance of the group.

Taxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual earnings. 

 

4. Seasonality

 

The group does not currently operate in an industry where significant or cyclical variations as a result of seasonal activity are experienced during the financial year. 

 

5. Dividend 

 

It is the board's policy that prior to making the first acquisition, no dividends will be paid. Following the first acquisition, subject to availability of distributable reserves, dividends will be paid to shareholders when the directors believe it is appropriate and prudent to do so. However, the main focus of the group will be on delivering capital growth for shareholders.

 6. Earnings per share

Basic earnings per share 

The calculation of basic earnings per share at 30 June 2009 (0.32p loss) was based on the loss attributable to ordinary shareholders of £435,050 and a weighted average number of ordinary shares outstanding of 136m.

The calculation of basic earnings per share at 30 June 2008 (0.46p loss) was based on the loss attributable to ordinary shareholders of £65,482 and a weighted average number of ordinary shares outstanding of 14.2m.

Diluted earnings per share  

The calculation of basic earnings per share at 30 June 2009 (0.32p loss) was based on the loss attributable to ordinary shareholders of £435,050 and a weighted average number of ordinary shares outstanding of 136m. The Participation Shares in issuance during the period are not included in the calculation of weighted average outstanding ordinary shares for the diluted earnings per share calculation as the effect is anti-dilutive.

The calculation of basic earnings per share at 30 June 2008 (0.46p loss) was based on the loss attributable to ordinary shareholders of £65,482 and a weighted average number of ordinary shares outstanding of 14.2m. The Participation Shares in issuance during the period are not included in the calculation of weighted average outstanding ordinary shares for the diluted earnings per share calculation as the effect is anti-dilutive.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR XLLFBKKBEBBV
Date   Source Headline
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights
31st May 202311:30 amRNSHolding(s) in Company
24th May 202312:35 pmRNSDirector/PDMR Shareholding
23rd May 20235:31 pmRNSHolding(s) in Company
22nd May 202311:24 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
18th May 20234:52 pmRNSDirector/PDMR Shareholding
18th May 20239:00 amRNSBreedon plays key role in Peak Cluster initiative
18th May 20238:00 amRNSAcquisitions
17th May 20238:00 amRNSReadmission - Breedon Group plc
17th May 20237:00 amRNSAdmission to Main Market
12th May 20236:00 pmRNSBreedon Group
12th May 20233:50 pmRNSDirector/PDMR Shareholding
11th May 202312:56 pmRNSPublication of Prospectus
4th May 202310:06 amRNSHolding(s) in Company
28th Apr 20237:00 amRNSHolding(s) in Company
26th Apr 20234:41 pmRNSResult of Scheme Meetings & Annual General Meeting
26th Apr 20237:00 amRNSAGM Trading Update
24th Apr 20232:22 pmRNSHolding(s) in Company
13th Apr 20236:08 pmRNSHolding(s) in Company
13th Apr 202312:12 pmRNSHolding(s) in Company
12th Apr 20234:50 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSPublication of Scheme Document
24th Mar 20233:49 pmRNSHolding(s) in Company
20th Mar 20239:00 amRNS2022 Annual Report and Notice of AGM
10th Mar 20235:34 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSResults of Reverse Accelerated Bookbuild
9th Mar 20234:56 pmRNSStatement re Reverse Accelerated Bookbuild
9th Mar 20231:36 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSIntention to move from AIM to the Main Market
8th Mar 20237:00 amRNSFinal Results
8th Feb 20238:00 amRNSNotice of Results
6th Feb 20231:29 pmRNSDirector/PDMR Shareholding
6th Jan 202310:08 amRNSBlocklisting Update
23rd Dec 202210:00 amRNSTotal Voting Rights
19th Dec 202212:57 pmRNSHolding(s) in Company
2nd Dec 20224:01 pmRNSHolding(s) in Company
30th Nov 20229:28 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSNovember trading statement
27th Oct 20224:23 pmRNSStandard form for notification of major holdings
26th Oct 20229:18 amRNSNotice of trading update
3rd Oct 20223:27 pmRNSPDMR Dealings
30th Sep 20224:20 pmRNSDirector Dealings
23rd Sep 20225:09 pmRNSStandard form for notification of major holdings
6th Sep 20225:19 pmRNSStandard form for notification of major holdings
25th Aug 20224:13 pmRNSDirector/PDMR Shareholding
27th Jul 20227:00 amRNSInterim results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.